In this clip, Dr. Bernstein discusses the ARTAS system for Robotic FUE and describes why having a computer-driven, image-guided robot is so helpful for hair transplantation.
NY1, a New York City television channel, has featured Dr. Bernstein in a segment on robotic hair transplantation.
In the piece, Dr. Bernstein describes why having a computer-driven, image-guided robot is so helpful for hair transplantation. He also discusses the quality of follicular units extracted using the robot.
Q: I wanted to find out about the difference between what Dr. Bernstein does with his robotic system versus NeoGraft. — G.M., Newark, NJ
A: The ARTAS robotic system, used at Bernstein Medical, has robotic control, video imaging and uses a blunt dissection technique. This allows for very precise extraction of follicular units from the donor area with minimal transection. The Neograft machine for FUE is a manually operated machine which uses sharp edge dissection. Because it relies on manual controls rather than robotics, it is less accurate and the cutting tip causes more graft injury. The precision of the robot allows the grafts to be harvested with less trauma and will thus result in better growth. In my opinion, these differences are very significant.
The February 2012 issue features a section on the “elite league of experts” who celebs are increasingly turning to in order to maintain their high profile image. The article describes Dr. Bernstein as a “pioneer in the world of hair replacement surgery,” and as the hair transplant surgeon of choice for “VIP clients from the world of fashion and entertainment.”
The January 2012 issue of the Journal of Drugs in Dermatology contains an article, written by Drs. Schweiger and Bernstein, which is the first case study of eyebrow growth from the topical use of bimatoprost.
Latisse (bimatoprost) is a topical medication that is FDA-approved for eyelash growth. Some physicians have used the medication for “off-label” use, such as use with eyelashes and scalp hair. However, until recently, there had not been any published medical literature describing the off-label use.
Castle Connolly has published the 11th edition of America’s Top Doctors. Dr. Bernstein is, once again, included on the peer-nominated list of doctors for his pioneering work in hair restoration.
The list represents just the top 1% of medical specialists in America. Dr. Bernstein is the first hair restoration physician to be named to this list for more than 10 consecutive years.
The New York Times, once again, has recognized Dr. Bernstein’s pioneering hair restoration techniques. The NYT Fashion and Style section noted that he is, “the first hair transplant surgeon on the east coast,” to use the ARTAS robotic system for Follicular Unit Extraction.
Dr. Bernstein’s pioneering work in developing FUT and FUE hair transplant procedures has influenced hair restoration physicians across the globe. Recently, his use of the ARTAS System for robotic FUE has grabbed international attention, as he was featured in a Japanese magazine.
In response to anecdotal evidence of sexual side effects continuing after stopping Propecia (finasteride 1mg), the International Society of Hair Restoration Surgery (ISHRS) has published a press release for the hair restoration community about the safety and efficacy of the drug. The release notes that scientific data gathered from extensive testing finds no correlation between persistent sexual dysfunction and Propecia.
You don’t have to be interested in a hair transplant to appreciate the advanced technology in the ARTAS system for robotic FUE.
That is why the technology and media website “All Things D” has featured the image-guided robot in an article titled, “All I Want for Christmas is a Robot Hair Transplant.”